Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-11-026075
Filing Date
2011-05-04
Accepted
2011-05-04 15:54:29
Documents
3
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 v220764_10ka.htm 10-K/A 63373
2 v220764_ex31-1.htm EX-31.1 18545
3 v220764_ex31-2.htm EX-31.2 18824
  Complete submission text file 0001144204-11-026075.txt   101872
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

EIN.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-53127 | Film No.: 11810282
SIC: 4731 Arrangement of Transportation of Freight & Cargo